WallStreetZenWallStreetZen

NASDAQ: ABEO
Abeona Therapeutics Inc Stock Ownership - Who owns Abeona Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Abeona Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mark AlvinoDirector2023-04-25887$3.25
$2.88kSell
Brendan M. OmalleySVP General Counsel2023-04-03104$2.82
$293.28Sell
Michael AmorosoDirector2023-03-20268$2.33
$624.44Sell
Joseph Walter VazzanoChief Financial Officer2023-03-15792$2.60
$2.06kSell
Michael AmorosoDirector2023-03-031,002$2.38
$2.38kSell
Brendan M. OmalleySVP General Counsel2023-03-03207$2.28
$471.96Sell
Brendan M. OmalleySVP General Counsel2022-12-095,869$3.13
$18.37kBuy
Brendan M. OmalleySVP General Counsel2022-11-187,500$3.99
$29.93kBuy
Joseph Walter VazzanoChief Financial Officer2022-11-182,500$4.00
$10.00kBuy
Vishwas SeshadriChief Executive Officer2022-10-17207$4.30
$890.10Sell

1 of 2

ABEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABEO insiders and whales buy or sell their stock.

ABEO Shareholders

What type of owners hold Abeona Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Sco Capital Partners LLC76.63%14,390,007$47.63MInsider
Steven H. Rouhandeh74.43%13,977,076$46.26MInsider
Ayer Capital Management LP12.85%2,413,163$7.99MInsider
B. Davis Jeffrey10.26%1,926,170$6.38MInsider
Nantahala Capital Management LLC7.61%1,428,675$4.73MInstitution
Adage Capital Partners GP LLC7.09%1,331,160$4.41MInstitution
Point72 Asset Management LP6.13%1,150,648$3.81MInstitution
Oracle Associates LLC4.79%900,400$2.98MInsider
Deerfield Management Company LP Series C4.63%869,565$2.88MInstitution
Aigh Capital Management LLC3.47%652,174$2.16MInstitution

1 of 3

ABEO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABEO17.05%82.95%Net SellingNet Selling
PRTG1.00%0.00%
HOOK40.49%21.01%
NRXP4.52%64.39%Net Buying
PRAX81.23%18.77%Net BuyingNet Buying
View Top Biotech Stocks

Abeona Therapeutics Stock Ownership FAQ

Who owns Abeona Therapeutics?

Abeona Therapeutics (NASDAQ: ABEO) is owned by 40.08% institutional shareholders, 195.00% Abeona Therapeutics insiders, and 0.00% retail investors. Sco Capital Partners LLC is the largest individual Abeona Therapeutics shareholder, owning 14.39M shares representing 76.63% of the company. Sco Capital Partners LLC's Abeona Therapeutics shares are currently valued at $47.63M.

If you're new to stock investing, here's how to buy Abeona Therapeutics stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.